Search Results - "Bryan, Brad A."

Refine Results
  1. 1

    RhoA/ROCK signaling is essential for multiple aspects of VEGF-mediated angiogenesis by Bryan, Brad A, Dennstedt, Emily, Mitchell, Dianne C, Walshe, Tony E, Noma, Kensuke, Loureiro, Robyn, Saint-Geniez, Magali, Campaigniac, Jean-Paul, Liao, James K, D'Amore, Patricia A

    Published in The FASEB journal (01-09-2010)
    “…The small GTPase RhoA and its downstream effectors, ROCK1 and ROCK2, regulate a number of cellular processes, including cell motility, proliferation, survival,…”
    Get full text
    Journal Article
  2. 2

    Targeting of beta adrenergic receptors results in therapeutic efficacy against models of hemangioendothelioma and angiosarcoma by Stiles, Jessica M, Amaya, Clarissa, Rains, Steven, Diaz, Dolores, Pham, Robert, Battiste, James, Modiano, Jaime F, Kokta, Victor, Boucheron, Laura E, Mitchell, Dianne C, Bryan, Brad A

    Published in PloS one (28-03-2013)
    “…Therapeutic targeting of the beta-adrenergic receptors has recently shown remarkable efficacy in the treatment of benign vascular tumors such as infantile…”
    Get full text
    Journal Article
  3. 3

    Propranolol Sensitizes Vascular Sarcoma Cells to Doxorubicin by Altering Lysosomal Drug Sequestration and Drug Efflux by Saha, Jhuma, Kim, Jong Hyuk, Amaya, Clarissa N, Witcher, Caleb, Khammanivong, Ali, Korpela, Derek M, Brown, David R, Taylor, Josephine, Bryan, Brad A, Dickerson, Erin B

    Published in Frontiers in oncology (01-02-2021)
    “…Angiosarcoma is a rare cancer of blood vessel-forming cells with a high patient mortality and few treatment options. Although chemotherapy often produces…”
    Get full text
    Journal Article
  4. 4

    Rho kinase proteins display aberrant upregulation in vascular tumors and contribute to vascular tumor growth by Amaya, Clarissa N, Mitchell, Dianne C, Bryan, Brad A

    Published in BMC cancer (14-07-2017)
    “…The serine/threonine protein kinases ROCK1 and 2 are key RhoA-mediated regulators of cell shape and cytoskeletal dynamics. These proteins perform multiple…”
    Get full text
    Journal Article
  5. 5

    Coordinated vascular endothelial growth factor expression and signaling during skeletal myogenic differentiation by Bryan, Brad A, Walshe, Tony E, Mitchell, Dianne C, Havumaki, Josh S, Saint-Geniez, Magali, Maharaj, Arindel S, Maldonado, Angel E, D'Amore, Patricia A

    Published in Molecular biology of the cell (01-03-2008)
    “…Angiogenesis is largely controlled by hypoxia-driven transcriptional up-regulation and secretion of vascular endothelial growth factor (VEGF) and its binding…”
    Get full text
    Journal Article
  6. 6

    Anti-angiogenic therapy: Adapting strategies to overcome resistant tumors by Mitchell, Dianne C., Bryan, Brad A.

    Published in Journal of cellular biochemistry (15-10-2010)
    “…Healthy cells, as well as benign and malignant tumors, depend upon the body's blood supply to bring in oxygen and nutrients and carry away waste products…”
    Get full text
    Journal Article
  7. 7

    The function of vascular endothelial growth factor by Nieves, Bonnie J., D'Amore, Patricia A., Bryan, Brad A.

    Published in BioFactors (Oxford) (01-07-2009)
    “…Vascular endothelial growth factor (VEGF) is considered the master regulator of angiogenesis during growth and development, as well as in disease states such…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Heterotypic mouse models of canine osteosarcoma recapitulate tumor heterogeneity and biological behavior by Scott, Milcah C, Tomiyasu, Hirotaka, Garbe, John R, Cornax, Ingrid, Amaya, Clarissa, O'Sullivan, M Gerard, Subramanian, Subbaya, Bryan, Brad A, Modiano, Jaime F

    Published in Disease models & mechanisms (01-12-2016)
    “…Osteosarcoma (OS) is a heterogeneous and rare disease with a disproportionate impact because it mainly affects children and adolescents. Lamentably, more than…”
    Get full text
    Journal Article
  11. 11

    Modulation of Muscle Regeneration, Myogenesis, and Adipogenesis by the Rho Family Guanine Nucleotide Exchange Factor GEFT by Bryan, Brad A., Mitchell, Dianne C., Zhao, Lei, Ma, Wenbin, Stafford, Lewis J., Teng, Ba-Bie, Liu, Mingyao

    Published in Molecular and Cellular Biology (01-12-2005)
    “…Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  12. 12

    Growth Attenuation of Cutaneous Angiosarcoma With Propranolol-Mediated β-Blockade by Chow, William, Amaya, Clarissa N, Rains, Steven, Chow, Michael, Dickerson, Erin B, Bryan, Brad A

    Published in JAMA dermatology (Chicago, Ill.) (01-11-2015)
    “…Patients with stage T2 multilesion angiosarcomas of the scalp and face that are larger than 10 cm demonstrate a 2-year survival rate of 0%. To our knowledge,…”
    Get more information
    Journal Article
  13. 13

    Beta Adrenergic Signaling: A Targetable Regulator of Angiosarcoma and Hemangiosarcoma by Dickerson, Erin B, Bryan, Brad A

    Published in Veterinary sciences (21-09-2015)
    “…Human angiosarcomas and canine hemangiosarcomas are highly aggressive cancers thought to arise from cells of vascular origin. The pathological features,…”
    Get full text
    Journal Article
  14. 14

    The Rho-family guanine nucleotide exchange factor GEFT enhances retinoic acid- and cAMP-induced neurite outgrowth by Bryan, Brad A., Cai, Yi, Liu, Mingyao

    Published in Journal of neuroscience research (15-05-2006)
    “…The Rho GTPases are important regulators of neurite outgrowth and pathfinding. We have recently reported that a Rho‐family guanine nucleotide exchange factor,…”
    Get full text
    Journal Article
  15. 15

    PD-1 and PD-L1 expression in bone and soft tissue sarcomas by Torabi, Alireza, Amaya, Clarissa N., Wians, Frank H., Bryan, Brad A.

    Published in Pathology (01-08-2017)
    “…PD-1 and its ligands have been shown to play a significant role in evasion of malignant tumour cells from the immune system. Last year, the Unites States Food…”
    Get full text
    Journal Article
  16. 16

    Rho Kinase Proteins-Pleiotropic Modulators of Cell Survival and Apoptosis by STREET, Catharine A, BRYAN, Brad A

    Published in Anticancer research (01-11-2011)
    “…Rho kinase (ROCK) proteins are Rho-GTPase activated serine/threonine kinases that function as modulators of actin-myosin cytoskeletal dynamics via regulation…”
    Get full text
    Journal Article
  17. 17

    GPR126 Protein Regulates Developmental and Pathological Angiogenesis through Modulation of VEGFR2 Receptor Signaling by Cui, Hengxiang, Wang, Yeqi, Huang, Huizhe, Yu, Wenjie, Bai, Min, Zhang, Long, Bryan, Brad A., Wang, Yuan, Luo, Jian, Li, Dali, Ma, Yanlin, Liu, Mingyao

    Published in The Journal of biological chemistry (12-12-2014)
    “…Angiogenesis, the formation of new blood vessels from pre-existing ones, is essential for development, wound healing, and tumor progression. The VEGF pathway…”
    Get full text
    Journal Article
  18. 18
  19. 19

    A patient organization perspective: charting the course to a cure for SCN2A-related disorders by Schust, Leah F., Burke, Jennifer, SanInocencio, Christina, Bryan, Brad A., Ho, Karen S., Egan, Shawn M.

    Published in Therapeutic advances in rare disease (01-01-2024)
    “…The SCN2A gene encodes the Nav1.2 protein, a voltage-gated sodium channel crucial for initiating and transmitting action potentials in neurons. Dysfunction in…”
    Get full text
    Journal Article
  20. 20